• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of jnnpsycJournal of Neurology, Neurosurgery and PsychiatryCurrent TOCInstructions for authors
J Neurol Neurosurg Psychiatry. Dec 1993; 56(12): 1295–1302.
PMCID: PMC1015377

Investigation of the opioid system in absence seizures with positron emission tomography.

Abstract

The neuroanatomical and pathophysiological basis of primary generalised absences is uncertain. Administration of endogenous opioids has been shown to result in absence-like seizures in animal models. Positron emission tomography scans were performed in eight patients with primary generalised epilepsy and eight control subjects. Regional cerebral blood flow was measured interictally with C15O2, after which a 90 minute dynamic study with the opioid-receptor ligand 11C-diprenorphine was performed. Serial absences were precipitated by hyperventilation for 10 minutes, starting 30-40 minutes after injection of diprenorphine. Absences, with generalised spike-wave discharges on the EEG, occurred for between 10% and 51% of the provocation period. No individual (normal or patient) had any interictal focal abnormalities of cerebral blood flow. After provocation of serial absence seizures, there was increased diprenorphine elimination from the association cortex, but not from the thalamus, basal ganglia, or cerebellum, compared with control subjects and patients scanned without provocation of absences. It was possible to simulate the observed increased diprenorphine elimination following seizures in cerebral cortex using a two tissue compartment model, with an estimated 15-41% decrease in the specific tracer uptake rate constant (k3). These results suggest that endogenous opioids are released in the association cortex at the time of serial absences, lead to increased receptor occupancy, and may have an important role in the pathophysiology of generalised absences.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Gloor P. Generalized epilepsy with spike-and-wave discharge: a reinterpretation of its electrographic and clinical manifestations. The 1977 William G. Lennox Lecture, American Epilepsy Society. Epilepsia. 1979 Oct;20(5):571–588. [PubMed]
  • Coulter DA, Huguenard JR, Prince DA. Differential effects of petit mal anticonvulsants and convulsants on thalamic neurones: calcium current reduction. Br J Pharmacol. 1990 Aug;100(4):800–806. [PMC free article] [PubMed]
  • Tortella FC, Long JB. Endogenous anticonvulsant substance in rat cerebrospinal fluid after a generalized seizure. Science. 1985 May 31;228(4703):1106–1108. [PubMed]
  • Vindrola O, Briones R, Asai M, Fernández-Guardiola A. Amygdaloid kindling enhances the enkephalin content in the rat brain. Neurosci Lett. 1981 Jan 1;21(1):39–43. [PubMed]
  • Hong JS, Wood PL, Gillin JC, Yang HY, Costa E. Changes of hippocampal Met-enkephalin content after recurrent motor seizures. Nature. 1980 May 22;285(5762):231–232. [PubMed]
  • Green AR, Peralta E, Hong JS, Mao CC, Atterwill CK, Costa E. Alterations in GABA metabolism and Met-enkephalin content in rat brain following repeated electroconvulsive shocks. J Neurochem. 1978 Sep;31(3):607–611. [PubMed]
  • Bajorek JG, Lee RJ, Lomax P. Neuropeptides: anticonvulsant and convulsant mechanisms in epileptic model systems and in humans. Adv Neurol. 1986;44:489–500. [PubMed]
  • Snead OC, 3rd, Bearden LJ. Anticonvulsants specific for petit mal antagonize epileptogenic effect of leucine enkephalin. Science. 1980 Nov 28;210(4473):1031–1033. [PubMed]
  • Haffmans J, Dzoljic MR. Effects of delta opioid antagonists on enkephalin-induced seizures. Pharmacology. 1987;34(2-3):61–65. [PubMed]
  • Ramabadran K, Bansinath M. Endogenous opioid peptides and epilepsy. Int J Clin Pharmacol Ther Toxicol. 1990 Feb;28(2):47–62. [PubMed]
  • Frey HH, Voits M. Effect of psychotropic agents on a model of absence epilepsy in rats. Neuropharmacology. 1991 Jun;30(6):651–656. [PubMed]
  • Neumaier JF, Chavkin C. Release of endogenous opioid peptides displaces [3H]diprenorphine binding in rat hippocampal slices. Brain Res. 1989 Jul 31;493(2):292–302. [PubMed]
  • Jones AK, Luthra SK, Maziere B, Pike VW, Loc'h C, Crouzel C, Syrota A, Jones T. Regional cerebral opioid receptor studies with [11C]diprenorphine in normal volunteers. J Neurosci Methods. 1988 Mar;23(2):121–129. [PubMed]
  • Sadzot B, Price JC, Mayberg HS, Douglass KH, Dannals RF, Lever JR, Ravert HT, Wilson AA, Wagner HN, Jr, Feldman MA, et al. Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography. J Cereb Blood Flow Metab. 1991 Mar;11(2):204–219. [PubMed]
  • Richards ML, Sadée W. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method. Eur J Pharmacol. 1985 Aug 27;114(3):343–353. [PubMed]
  • Friston KJ, Passingham RE, Nutt JG, Heather JD, Sawle GV, Frackowiak RS. Localisation in PET images: direct fitting of the intercommissural (AC-PC) line. J Cereb Blood Flow Metab. 1989 Oct;9(5):690–695. [PubMed]
  • Theodore WH, Brooks R, Margolin R, Patronas N, Sato S, Porter RJ, Mansi L, Bairamian D, DiChiro G. Positron emission tomography in generalized seizures. Neurology. 1985 May;35(5):684–690. [PubMed]
  • Simantov R, Lotem J, Levy R. Selectivity in the control of opiate receptor density in the animal and in cultured fetal brain cells. Neuropeptides. 1984 Dec;5(1-3):197–200. [PubMed]
  • Martin WR, Powers WJ, Raichle ME. Cerebral blood volume measured with inhaled C15O and positron emission tomography. J Cereb Blood Flow Metab. 1987 Aug;7(4):421–426. [PubMed]
  • Tortella FC, Cowan A. Studies on opioid peptides as endogenous anticonvulsants. Life Sci. 1982 Nov 15;31(20-21):2225–2228. [PubMed]
  • Tortella FC. Endogenous opioid peptides and epilepsy: quieting the seizing brain? Trends Pharmacol Sci. 1988 Oct;9(10):366–372. [PubMed]
  • Patel VK, Abbott LC, Rattan AK, Tejwani GA. Increased methionine-enkephalin levels in genetically epileptic (tg/tg) mice. Brain Res Bull. 1991 Dec;27(6):849–852. [PubMed]
  • Mayberg HS, Sadzot B, Meltzer CC, Fisher RS, Lesser RP, Dannals RF, Lever JR, Wilson AA, Ravert HT, Wagner HN, Jr, et al. Quantification of mu and non-mu opiate receptors in temporal lobe epilepsy using positron emission tomography. Ann Neurol. 1991 Jul;30(1):3–11. [PubMed]
  • Lee RJ, McCabe RT, Wamsley JK, Olsen RW, Lomax P. Opioid receptor alterations in a genetic model of generalized epilepsy. Brain Res. 1986 Aug 13;380(1):76–82. [PubMed]
  • Jackson HC, Nutt DJ. Differential effects of selective mu-, kappa- and delta-opioid antagonists on electroshock seizure threshold in mice. Psychopharmacology (Berl) 1991;103(3):380–383. [PubMed]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...